Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The global cell and gene therapy supply chain software market was valued at USD 1.62 Billion in 2025, driven by the increasing prevalence of genetic disorders, cancer, and other chronic conditions across the globe. The market is anticipated to grow at a CAGR of 11.20% during the forecast period of 2026-2035, with the values likely to reach USD 4.68 Billion by 2035.
Q1 2026 Market Updates
Geopolitical Impact of Iran, US, and Israel War on the Cell and Gene Therapy Supply Chain Software Market
United States: The Cell and Gene Therapy Supply Chain Software Market, a key segment of the global economy, is experiencing a complex operating environment in Q1 2026 as a direct consequence of the US-Israel-Iran war. IDC revised U.S. IT spending growth from 12.4% to 11.4% for 2026, with similar revisions across other markets as corporate CFOs apply caution in an inflationary, uncertain macroeconomic environment. Microsoft Azure and AWS reported investigating latency spikes at Middle Eastern data center nodes following missile strikes on Dubai and Doha infrastructure. Semiconductor and electronics supply chains routed through the Gulf region are experiencing disruption, with some production inputs stranded aboard ships unable to transit the Strait of Hormuz. IDC revised U.S. IT spending growth from 12.4% to 11.4% for 2026, reflecting corporate caution in an inflationary environment. Despite overall caution, AI-driven infrastructure investment continues to provide structural demand support. Despite spending caution, AI infrastructure investment continues to grow, with the current crisis reinforcing the case for advanced technology adoption to offset rising labor and materials costs.
Iran: Iran's domestic Cell and Gene Therapy Supply Chain Software sector has been effectively suspended by the conflict. US-Israeli strikes on industrial and civilian infrastructure across Tehran, Mashhad, Isfahan, and other major cities have disrupted all commercial activity. Power outages from attacks on electricity generation facilities have halted manufacturing operations, and the collapse of the commercial banking and logistics system has eliminated any residual trade flows. The broader humanitarian crisis, with over 1,900 casualties and 4,000+ civilian buildings damaged, has redirected the entire Iranian economy toward survival rather than production or consumption.
Israel: Israel's technology sector, a globally significant innovation hub for cybersecurity, semiconductors, AI, and various specialized verticals, is experiencing operational disruption as engineering teams are reduced by military reservist call-ups. Several Israeli companies supply components, software, and services to global Cell and Gene Therapy Supply Chain Software market participants. Business development activities have been suspended, and some operational timelines extended. However, Israel's proven resilience through previous conflict periods, and the continued operation of critical R&D programmes, suggests the disruption will be temporary rather than structural.
Key Takeaways
Government
- Relevant technology procurement agencies should assess exposure to Gulf-region cloud and semiconductor supply chains, ensuring critical government IT systems have geographic redundancy and are not dependent on disrupted Middle Eastern infrastructure.
- Policymakers should consider technology investment incentives to offset IDC's revised 11.4% U.S. IT spending growth forecast, preventing conflict-driven corporate caution from permanently deferring productive technology capital investment.
- Cybersecurity agencies should elevate threat assessment for government and critical infrastructure systems, as the Iran conflict has been accompanied by extensive cyber operations targeting energy, financial, and communication infrastructure.
Market
- IDC's downward revision of IT spending growth from 12.4% to 11.4% reflects genuine corporate caution, but the structural AI-driven investment cycle remains intact, with the conflict actually creating additional demand for automation, supply chain visibility, and remote operation technology.
- Microsoft Azure and AWS reports of latency spikes at Middle Eastern data center nodes are accelerating enterprise multi-region architecture adoption and geographic redundancy investments that strengthen Ethernet and cloud infrastructure demand.
- The cell and gene therapy supply chain software market benefits from the conflict as a demand catalyst in customer-facing applications, as businesses managing supply chain complexity, customer inquiry volumes, and remote operations require scalable technology platforms at unprecedented scale.
Procurement
- Enterprise technology procurement teams should assess Gulf-region cloud infrastructure exposure and request vendor confirmation that critical SaaS and IaaS services have adequate geographic redundancy outside the conflict zone.
- IT procurement managers should advance planned technology deployments from discretionary to priority status where the platform addresses supply chain visibility, remote operations, or customer communication challenges created by the conflict.
- Technology buyers should review semiconductor and electronics supply chains for Gulf-adjacent manufacturing exposure, building buffer inventory for critical components that may face supply disruption.
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
-
The market is poised for significant growth as the demand for efficient, data-driven logistics and real-time monitoring increases in response to complex biomanufacturing processes.
-
Rising regulatory complexities and the need for greater transparency in gene therapy manufacturing are driving the adoption of supply chain software solutions, fostering improved compliance and risk management.
-
With the expansion of personalised medicine and biopharmaceutical innovations, the market for cell and gene therapy supply chain software is expected to witness substantial investment in automation and AI-driven technologies for optimised operations.
Cell and Gene Therapy Supply Chain Software Market Overview
Cell and gene therapy supply chain software is designed to optimise the logistics, storage, and distribution of biological products. It addresses the unique challenges of managing temperature-sensitive therapies, ensuring regulatory compliance, and tracking product integrity throughout the supply chain. This software enhances efficiency, transparency, and security, supporting the growth and scalability of the cell and gene therapy industry.
Cell and Gene Therapy Supply Chain Software Market Growth Drivers
Strategic Collaborations to Boost Market Growth
The increasing demand for efficient manufacturing solutions and advancements in data analytics are key drivers for market growth. In April 2024, Autolomous, a leader in manufacturing management systems, partnered with BioCentriq, a clinical-phase Cell Therapy CDMO. Their collaboration aims to revolutionise the process development and manufacturing of cell and gene therapies through Autolomous' innovative autoloMATE® platform. This fully cloud-native, no-code software is designed to improve data capture, operational logistics, and tech transfer. It will empower BioCentriq to optimise efficiency while ensuring top-tier quality and data integrity, significantly enhancing the capabilities of the cell and gene therapy sector. This partnership is poised to positively influence the market's growth in the forecast period, driving demand for advanced software solutions in process development and manufacturing.
Emphasis on Expertise and Precision to Foster Cell and Gene Therapy Supply Chain Software Market Demand
The rising complexity of clinical trials and regulatory requirements in the cell and gene therapy sector are driving the need for specialised supply chain software solutions. For instance, in January 2024, TrakCel, a recognised leader in cellular orchestration systems, launched its Consultancy Services aimed at providing valuable expertise to CGT developers. This service focuses on critical areas such as Chain of Identity Strategy, Data Protection Compliance, and Supply Chain Risk Assessment, addressing the unique challenges faced by therapy developers. By offering their extensive process development experience, TrakCel is poised to streamline operations, mitigate risks, and improve compliance, supporting the growth and evolution of the cell and gene therapy supply chain. This initiative will play a key role in accelerating the market’s expansion over the coming years, reinforcing the demand for expert-driven solutions in supply chain management.
Cell and Gene Therapy Supply Chain Software Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Cell and Gene Therapy Supply Chain Software Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Enterprise Manufacturing System (EMS)
- Laboratory Information Management System (LIMS)
- Inventory Management System (IMS)
- Quality Management System (QMS)
- Logistics Management System (LMS)
- Patient Management System (PMS)
- Others
Market Breakup by Application
- Manufacturing Component
- Sample Collection and Processing Component
- Logistics Component
- Patient Identification and Treatment Follow-up Component
- Others
Market Breakup by Deployment
- On-premises Deployment
- Cloud-based Deployment
Market Breakup by End User
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Biobanks
- Research and Academic Institutes
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Cell and Gene Therapy Supply Chain Software Market Share
Market Segmentation Based on End Users to Witness Significant Growth
Pharmaceutical and biotechnology companies are likely to lead the market share based on end users, primarily due to the increasing development and commercialisation of advanced cell and gene therapies by pharmaceutical and biotechnology firms. These companies require robust software solutions to manage the complexities of gene therapy supply chains, including cold-chain logistics, regulatory compliance, and ensuring product integrity from production to delivery. The growing investment in gene therapies, particularly for rare and chronic diseases, is driving the demand for efficient, secure, and scalable supply chain solutions in this segment, giving it a dominant market share.
Cell and Gene Therapy Supply Chain Software Market Analysis by Region
North America leads the market due to its robust healthcare infrastructure, high adoption of advanced technologies, and a growing number of biopharma companies focused on gene and cell therapies. The presence of key industry players, strong regulatory support, and significant investments in research and development further propel market growth. Additionally, the rising demand for personalised medicine and innovative therapies in the region strengthens North America's dominant market share.
Leading Players in the Cell and Gene Therapy Supply Chain Software Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Azenta Life Sciences
Headquartered in Chelmsford, Massachusetts, Azenta Life Sciences was established in 2021. The company provides a comprehensive portfolio of integrated solutions for the cell and gene therapy supply chain, including cold-chain logistics, sample management, and automated storage systems. Azenta’s technologies are designed to ensure safe, efficient transportation and storage of biologics and gene therapy products globally.
Biocair
Founded in 1987 and headquartered in the UK, Biocair specialises in providing logistics and supply chain solutions for the life sciences industry. Its portfolio includes cold-chain transportation, temperature-controlled packaging, and specialised courier services tailored to cell and gene therapies. Biocair’s global presence ensures secure, compliant handling of complex biological products, supporting the growing demand for gene therapy supply chains.
BioLife Solutions
BioLife Solutions, based in Bothell, Washington, was established in 1987. The company offers advanced cell and gene therapy supply chain solutions, including cryopreservation media, controlled-rate freezers, and automated thawing systems. BioLife’s products support the safe storage, transport, and handling of biologics, particularly for cell and gene therapy applications, ensuring the preservation of critical therapies across the supply chain.
Cryoport Systems, LLC.
Cryoport Systems, LLC. is a leading provider of supply chain solutions for the life sciences industry, with a particular focus on temperature-controlled logistics for biological materials. Their services are crucial for industries such as cell and gene therapy, which require precise handling and transportation of sensitive materials like cells, tissues, and gene-modified products.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Lonza, NMDP BioTherapies, TraceLink Inc., LabVantage Solutions Inc., and TrakCel.
Key Questions Answered in the Cell and Gene Therapy Supply Chain Software Market
- What was the cell and gene therapy supply chain software market value in 2025?
- What is the cell and gene therapy supply chain software market forecast outlook for 2026-2035?
- What is the market breakup based on the type?
- What is the market breakup based on the application?
- What is the market breakup based on the deployment?
- What is the market breakup based on the end user?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- Which country is expected to experience expedited growth during the forecast period?
- What are the major cell and gene therapy supply chain software market trends?
- Which type will lead the market segment?
- Which application will lead the market segment?
- Which deployment will lead the market segment?
- Which end user will lead the market segment?
- Who are the key players involved in the cell and gene therapy supply chain software market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$3299 $2969
-
$5499 $4949
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by Deployment Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share